Study Stopped
Due to lack of enrollment.
Caloric Intake and Ovarian Reserve
1 other identifier
observational
N/A
1 country
1
Brief Summary
The goal of this study is to observe the impact of caloric intake on ovarian reserve as measured by anti-müllerian hormone (AMH) levels and antral follicles (AFC) visualized on ultrasound. It has been shown that obesity negatively impacts these markers, but research is lacking regarding the influence of nutrition and caloric intake on fertility. This would give the investigators information on how diet may impact ovarian reserve in patients seeking fertility treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2018
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedStudy Start
First participant enrolled
January 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedJanuary 9, 2020
January 1, 2020
1.3 years
July 19, 2018
January 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Average Daily Caloric Intake
Patients will complete a food diary that they will complete over a 3 day period to assess their average caloric intake.
3 days
Study Arms (1)
Women seeking fertility treatment
Women aged 18-45 who are seeking fertility treatment at Bethesda Fertility Center will be provided a survey and food diary to complete.
Interventions
Patients will be provided with a 8 question patient survey to complete and return, as well as a food diary that they will complete over a 3 day period to assess their average caloric intake.
Eligibility Criteria
Women aged 18-45 who are seeking fertility treatment at the Bethesda Fertility Center
You may qualify if:
- Women aged 18-45 who are seeking fertility treatment at Bethesda Fertility Center will be included.
You may not qualify if:
- Women who have a diagnosis of PCOS will be excluded from the study due to their abnormal AMH and follicle numbers.
- Women will be excluded if more than 12 months has passed since AMH and AFC levels have been measured.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TriHealth Inc.lead
Study Sites (1)
Bethesda Fertility Center
Cincinnati, Ohio, 45220, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kasey Reynolds, MD
TriHealth Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2018
First Posted
July 27, 2018
Study Start
January 14, 2019
Primary Completion
May 1, 2020
Study Completion
May 1, 2020
Last Updated
January 9, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share